Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,227,509
-
Total 13F shares
-
102,126,793
-
Share change
-
-6,683,646
-
Total reported value
-
$3,952,163,523
-
Put/Call ratio
-
360%
-
Price per share
-
$38.92
-
Number of holders
-
282
-
Value change
-
-$223,082,374
-
Number of buys
-
135
-
Number of sells
-
143
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q2 2014
As of 30 Jun 2014,
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by
282 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
102,126,793 shares.
The largest 10 holders included
ROYCE & ASSOCIATES LLC, BAILLIE GIFFORD & CO, Capital Research Global Investors, Capital World Investors, VANGUARD GROUP INC, SCOPIA CAPITAL MANAGEMENT LLC, FIRST TRUST ADVISORS LP, IRIDIAN ASSET MANAGEMENT LLC/CT, TIGER GLOBAL MANAGEMENT LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
282
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.